New topics referred to nice
The following topics have been referred to NICE by the Secretary of State for Health for its forward work programme, in line with the national priorities established for the NHS:
Clinical guidelines:
• recognition and initial management of ovarian cancer
• management of alcohol dependence
• diagnosis, prevention and management of delirium
• management of stable angina
• recognition and diagnosis of Coeliac disease in adults
Public health guidance:
• prevention of unintentional injury in children under 15
• prevention of cardiovascular disease at the population level
• children in care
Single technology appraisals:
• sorafenib for advanced hepatocellular carcinoma
• dasatinib for acute lymphoblastic leukaemia
• nilotinib for acute lymphoblastic leukaemia
• eltrombopag for refractory chronic immune (idiopathic) thrombocytopenic purpura
• AMG 531 for refractory chronic immune (idiopathic) thrombocytopenic purpura
• abatacept for juvenile idiopathic arthritis
• tenofovir for chronic hepatitis B
• xaliproden for Alzheimer’s disease
• prasugrel for acute coronary artery syndromes with percutaneous coronary intervention
• detemir for type 1 diabetes mellitus
• temozolomide for advanced and metastatic melanoma
• liposomal muramyl tripetide phosophatidyl ethanolamine as an addition to adjuvant chemotherapy for newly diagnosed, non-metastatic, resectable osteosarcoma
Multiple technology appraisals:
• dasatinib and nilotinib for imatinib-resistant chronic myeloid leukaemia
• topotecan for relapsed small cell lung cancer
• adalimumab and etanercept for polyarticular juvenile arthritis (including a review of TA35). (Source: NeLM Headline News)
http://www.nelm.nhs.uk/Record%20Viewing/viewRecord.aspx?id=586659
